Answers are grounded in this paper and cite their sources.
The spread of respiratory viruses, such as influenza and SARS-CoV-2, has presented significant challenges over the last 30 years, with few effective therapeutic options available to this day. Bicyclic peptides represent a unique, modular modality in the antiviral armamentarium against future pandemics. This study utilizes tool molecules to provide a deeper evaluation of multivalent bicyclic (Bicycle) molecule efficacy in several preclinical SARS-CoV-2 challenge settings. We explore both pre-exposure prophylaxis and post-exposure therapeutic settings via subcutaneous and intranasal routes of administration. We contextualize this further in bespoke scenarios where the immune system is compromised, as well as viral transmission. Promisingly, in all studies, we observe efficacy, significantly reducing infectious viral burden at each study endpoint. These data further support the candidacy of Bicycle molecules as a differentiated antiviral therapeutic class in the context of pandemic preparedness. IMPORTANCE: The COVID-19 pandemic triggered a rapid wave of innovation, accelerating the delivery of new vaccine technology and antiviral treatments. In our first paper, we described the discovery and molecular optimization of Bicycle molecules as a novel drug class for the potential treatment of SARS-CoV-2. Here, we have performed deeper characterization of these tool molecules in established animal models to evaluate scenarios for deployment, simulating SARS-CoV-2 transmission, testing more convenient delivery routes, such as intranasal, as well as looking at immunocompromised animals. The Bicycle molecules demonstrated positive outcomes in each of these studies and suggest that Bicycle molecules, as convenient and effective antiviral treatments, could be an important addition to help future preparedness against new viral pandemics.
No takes yet. Share an insight, caveat, or question.
Harman et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: